The Molecular Architecture of GHK-Cu & AHK-Cu Peptides
Share
Four variants. One copper ion. Vastly different molecular weights, structures, and skin outcomes — a look at copper peptide chemistry, and why it matters for product choice.
Read the original thread on X →
What GHK-Cu actually is
For the variants to make sense, we'll start with the base molecule. GHK-Cu is a copper peptide — a naturally occurring tripeptide found in human plasma, saliva, and urine — consisting of three amino acids: glycine (Gly), histidine (His), and lysine (Lys), chelated to a single copper (Cu²⁺) ion. The body produces it abundantly in youth, deploying it as a wound-repair and tissue-remodeling signal. By age 60, plasma concentrations have fallen by more than 60%.
The copper ion isn't blue decoration — it's structural and functional. Histidine coordinates the copper through its imidazole nitrogen, while the terminal amine of glycine provides a second coordination site. This creates a stable chelate — a closed-ring structure — that gives GHK-Cu its characteristic colour and its ability to carry the element into biological tissue without releasing free copper ions that could cause oxidative damage.
That stability is what makes GHK-Cu formulation-worthy. Free copper is pro-oxidant. Chelated copper, in this context, behaves as a cofactor for lysyl oxidase (the enzyme that crosslinks collagen and elastin), superoxide dismutase (a key antioxidant enzyme), and cytochrome c oxidase (a driver of cellular energy production). The tripeptide is essentially a copper chaperone — delivering the metal precisely where tissue repair demands it.
The four variants — and why they differ
The commercial market offers not one GHK-Cu, but four distinct molecular forms. They share the same three amino acids and the same copper ion, but differ in stoichiometry, counterion, molecular weight, copper density, and formulation behaviour. Understanding these differences isn't academic — it determines what you can and can't do with each form in a cosmetic or clinical context. (Side note: if you ever see a vial of white GHK, that's the base form of the peptide without bound copper — the first entry in the chart below.)

Molecular weight as a penetration proxy
Molecular weight matters in skin science because the stratum corneum — the outermost barrier layer of the epidermis — is selectively permeable. The widely cited “500 Dalton rule,” first described by Bos and Meinardi in 2000, holds that molecules above approximately 500 daltons cannot penetrate intact skin to any therapeutically meaningful degree through passive diffusion alone.
This rule isn't absolute. Lipophilicity, molecular geometry, formulation vehicle, and delivery technology (microneedling, sonophoresis, iontophoresis) all modulate penetration — but as a practical baseline for topical cosmetic formulation, it remains one of the most useful heuristics in the field. With that in mind, the four variants sit in meaningfully different positions relative to that threshold.
GHK — the free peptide (340.39 Da)
The copper-free tripeptide at 340.39 Da is the lightest of the four, and structurally the simplest: C₁₄H₂₄N₆O₄ — pure GHK with no metal chelation, a white powder rather than blue. Its lower molecular weight makes it the most theoretically penetrant of the four, sitting 160 Da below the threshold with room to spare.
Free GHK retains some biological signalling activity independent of copper. It can bind to collagen fragments and influence tissue-remodeling pathways. It is also the only variant compatible with the full range of acidic actives without risk of complex disruption, and the cleanest to formulate with — no pH constraints from a copper counterion, no blue discolouration risk. The trade-off is the absence of copper cofactor function: no lysyl oxidase activation, no direct collagen-crosslinking support. It's sold by injectable peptide manufacturers in lyophilized form — though a buyer expecting blue may be surprised to receive a white powder.
GHK-Cu 1:1 — the compact workhorse (401.91 Da)
GHK-Cu 1:1 (Copper Tripeptide-1) at 401.91 Da is the molecular workhorse of copper peptide science: one GHK tripeptide, one copper ion, one hydrochloride counterion. The molecular formula C₁₄H₂₂CuN₆O₄ represents the most compact biologically active copper-chelated form of GHK available.
At 401.91 Da it sits comfortably below the 500 Da penetration threshold. This is the form preferred in aesthetic medicine for injectable applications, where the copper peptide is delivered subcutaneously — and it's also the form preferred for topical cosmetic use.
At Mycena, the Certificate of Analysis (COA) for our current batch shows 99.87% purity and 13.74% copper — near the top of the 8–16% specification range, making this batch copper-dense and highly pure. Its pH in a 1% water solution is 5.68, reflecting the mildly acidic character of the HCl salt form, which we lower very slightly in formulation.
AHK-Cu — the hair variant (415.12 Da)
AHK-Cu breaks from the GHK structure in a fundamental way: the first amino acid is not glycine (Gly) but alanine (Ala), giving a sequence of Ala-His-Lys rather than Gly-His-Lys. This single substitution adds one methyl group to the backbone — glycine has no side chain, whereas alanine carries a methyl side chain (–CH₃) — which explains the modest mass increase to 415.12 Da, just 13.21 Da heavier than GHK-Cu 1:1.
That 13.21 Da difference might seem trivial, but the biological consequences of the alanine substitution are not. The altered N-terminus changes how the peptide presents its copper-binding geometry and, more importantly, changes receptor recognition.
AHK-Cu has been studied specifically for hair-follicle applications, and its primary research association is with hair-growth support rather than collagen induction. At 415.12 Da it stays beneath the 500 Da threshold, making it a strong candidate for scalp applications where the copper needs to reach dermal papilla cells — the stem-cell population that governs follicle cycling.
GHK-Cu 2:1 — the double-chain complex (742.29 Da)
GHK-Cu 2:1 (Bis(Tripeptide-1) Copper Acetate) is where the chemistry diverges most sharply. At 742.29 Da, this molecule consists of two full GHK tripeptide chains wrapping a single copper ion, stabilized by acetate counterions. The formula C₂₈H₄₅CuN₁₂O₈ is essentially a doubled peptide backbone chelating one Cu²⁺ — think of it as the 1:1 molecule holding hands with an identical twin, sharing one copper between them.
The structural consequence is significant. With two peptide chains sharing one copper, copper content by mass drops to 4–8% — roughly half that of the 1:1 form. Per milligram, you're buying more amino acid and less copper. Whether that's a disadvantage depends entirely on what you're optimizing for: if the goal is copper delivery, the 1:1 wins by density; if the goal is a more stable, slowly-releasing copper complex with a gentler pH profile, the 2:1 form has merit.
More critically, at 742 Da this variant exceeds the 500 Da rule substantially, so passive transdermal penetration is significantly limited. This doesn't make it useless in topical formulations — studies have shown that even larger molecules can penetrate via follicular routes and in compromised-barrier states — but delivery expectations must be calibrated accordingly. The 2:1 form is better understood as a surface-active, follicle-targeting ingredient than a deep dermal penetrant.
The amino acid substitution — why one methyl group changes everything

The structural difference between GHK-Cu and AHK-Cu comes down to a single atom swap at the N-terminus: the hydrogen side chain of glycine (–H) replaced by the methyl side chain of alanine (–CH₃). On paper this is a modest change — one carbon, three hydrogens, 13.21 extra daltons.
In biochemistry, that swap at the N-terminal position changes the steric environment around the copper coordination site. The N-terminal amine is one of the two primary copper-binding anchors in the GHK chelate. Placing alanine here — with its bulkier side chain projecting into space — subtly alters the angle and geometry of copper coordination. This geometric difference is enough to shift receptor affinity: AHK-Cu preferentially activates pathways associated with hair-follicle cycling and scalp repair rather than the dermal-fibroblast pathways targeted by GHK-Cu.
The copper content (8–12%) and molecular weight (415.12 Da) remain comfortably within the zone of known efficacy — close enough to GHK-Cu 1:1 that many of the same formulation principles apply, but biologically distinct enough that the two are not interchangeable.
Copper Theory, Scalp Theory, Vital Theory
Our Copper Theory daily skin serum pairs copper tripeptide GHK-Cu 1:1 (Copper Tripeptide-1) with the tremella beauty mushroom in a hyaluronic-acid base for visible repair and firmness. Scalp Theory, for scalp and hair, uses copper tripeptide AHK-Cu (Copper Tripeptide-3) with salicylic acid and caffeine for a healthy scalp and fuller-looking hair. And Vital Theory combines cordyceps militaris and tremella with niacinamide for everyday renewal and radiance.
These statements have not been evaluated by the Food and Drug Administration. Mycena products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. Ingredient research is provided for education and describes the ingredients, not claims about finished-product performance.